Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.

Taha M Hassanin Yasser Mahrous FouadAlshymaa HassnineMohamad EisawyNaglaa FaragWael Abdel Ghany

Published in: Asian Pacific journal of cancer prevention : APJCP (2021)

Neither TACE nor TACE-RFA showed a significant decrease in QoL in patients with unresectable HCC two weeks after intervention. However, two months after intervention; TACE-RFA showed significant improvement in global health score compared to TACE monotherapy. TACE-RFA appeared safe, effective and more favorable than TACE monotherapy.<br />.

Keyphrases

radiofrequency ablation
global health
randomized controlled trial
public health
locally advanced
combination therapy
open label
clinical trial
liver metastases
gestational age
study protocol
double blind